Marzieh Salehi

This study is testing if the diabetes and weight-loss drug semaglutide (Ozempic) works well for people who have both a spinal cord injury and type 2 diabetes. About 50 participants will receive either the real drug or a placebo injection once a week for 24 weeks. Researchers will…